News | New Gene-Editing Findings: Human Embryos Have Limited DNA Repair Capacity
Findings published by a research team led by Dr. Nada Kubikova of the University of Oxford in the United Kingdom raise a serious warning about using gene-editing technology in early human embryos. The results show that early embryonic cells have limited capacity to repair DNA damage, with important implications for the safety of using gene editing to prevent inherited diseases. The study was presented at the 39th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).
Gene Editing: Potential and Risk
Dr. Kubikova noted that although CRISPR-Cas9 has the potential to correct defective genes, its use in early embryos may have adverse consequences. The study found that CRISPR efficiently targeted the intended DNA region, but only 9% of DNA damage was repaired through homology-directed repair (HDR), the key method for clinically correcting genetic mutations. In more than half of cases, DNA breaks were repaired through non-homologous end joining (NHEJ), a process that can introduce new mutations. Up to 40% of DNA breaks remained unrepaired, causing large chromosomal deletions or duplications.
These abnormalities may prevent embryonic development and, even after successful implantation, increase the risk of serious congenital disorders.
Study Design: Revealing DNA Repair Mechanisms
In an ethically approved experiment, the team created 84 embryos using intracytoplasmic sperm injection (ICSI). Of these, 33 were treated with CRISPR-Cas9 to create double-strand DNA breaks, while the remaining 51 served as controls. Even when the target region did not involve a specific gene, embryonic cells favored NHEJ to repair DNA damage. This mechanism can delete or duplicate “letters” of the genetic code and disrupt gene function.
The Future of Gene Editing: Improving Technology and Protecting Embryos
Although the study cautions against current methods, it also offers hope. Dr. Kubikova said that adjusting gene-editing techniques may reduce risks and improve repair efficiency. The findings may also offer new ways to improve in vitro fertilization (IVF), as only about one-quarter of IVF embryos currently develop into babies.
The team plans to explore how to protect early embryos from DNA damage and develop gentler gene-editing methods that do not involve DNA breaks. These efforts may eventually make it possible to safely reverse inherited mutations and prevent some serious genetic diseases from passing between generations.
Ethics and Regulation: Gene Editing Requires Caution
ESHRE Chair-Elect Professor Karen Sermon commented that the study underscores the need for comprehensive, careful research before gene editing is used in human embryos. Although gene editing may one day become an important tool for preventing inherited diseases, its safety and effectiveness are far from fully understood.
Dr. Kubikova concluded: “Although current findings show that major challenges remain in using CRISPR in embryos, future technical advances may open a safe path for gene editing and help many families avoid inherited diseases.”
News | New Gene-Editing Findings: Human Embryos Have Limited DNA Repair Capacity
News | New Gene-Editing Findings: Human Embryos Have Limited DNA Repair Capacity
Findings published by a research team led by Dr. Nada Kubikova of the University of Oxford in the United Kingdom raise a serious warning about using gene-editing technology in early human embryos. The results show that early embryonic cells have limited capacity to repair DNA damage, with important implications for the safety of using gene editing to prevent inherited diseases. The study was presented at the 39th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).
Gene Editing: Potential and Risk
Dr. Kubikova noted that although CRISPR-Cas9 has the potential to correct defective genes, its use in early embryos may have adverse consequences. The study found that CRISPR efficiently targeted the intended DNA region, but only 9% of DNA damage was repaired through homology-directed repair (HDR), the key method for clinically correcting genetic mutations. In more than half of cases, DNA breaks were repaired through non-homologous end joining (NHEJ), a process that can introduce new mutations. Up to 40% of DNA breaks remained unrepaired, causing large chromosomal deletions or duplications.
These abnormalities may prevent embryonic development and, even after successful implantation, increase the risk of serious congenital disorders.
Study Design: Revealing DNA Repair Mechanisms
In an ethically approved experiment, the team created 84 embryos using intracytoplasmic sperm injection (ICSI). Of these, 33 were treated with CRISPR-Cas9 to create double-strand DNA breaks, while the remaining 51 served as controls. Even when the target region did not involve a specific gene, embryonic cells favored NHEJ to repair DNA damage. This mechanism can delete or duplicate “letters” of the genetic code and disrupt gene function.
The Future of Gene Editing: Improving Technology and Protecting Embryos
Although the study cautions against current methods, it also offers hope. Dr. Kubikova said that adjusting gene-editing techniques may reduce risks and improve repair efficiency. The findings may also offer new ways to improve in vitro fertilization (IVF), as only about one-quarter of IVF embryos currently develop into babies.
The team plans to explore how to protect early embryos from DNA damage and develop gentler gene-editing methods that do not involve DNA breaks. These efforts may eventually make it possible to safely reverse inherited mutations and prevent some serious genetic diseases from passing between generations.
Ethics and Regulation: Gene Editing Requires Caution
ESHRE Chair-Elect Professor Karen Sermon commented that the study underscores the need for comprehensive, careful research before gene editing is used in human embryos. Although gene editing may one day become an important tool for preventing inherited diseases, its safety and effectiveness are far from fully understood.
Dr. Kubikova concluded: “Although current findings show that major challenges remain in using CRISPR in embryos, future technical advances may open a safe path for gene editing and help many families avoid inherited diseases.”
Source:
Collected online